Loading...
XSHG603716
Market cap207mUSD
Dec 24, Last price  
8.07CNY
1D
-3.24%
1Q
31.22%
Jan 2017
-77.59%
IPO
-33.74%
Name

Thalys Medical Technology Group Corp

Chart & Performance

D1W1MN
XSHG:603716 chart
P/E
—
P/S
0.75
EPS
—
Div Yield, %
2.57%
Shrs. gr., 5y
0.13%
Rev. gr., 5y
8.77%
Revenues
2.01b
-13.10%
193,737,748283,166,616392,180,017445,045,201529,659,702627,328,056920,516,5441,317,446,0521,830,771,6162,125,471,6032,599,547,3482,308,631,6552,006,134,334
Net income
-159m
37,782,40038,330,98049,064,42456,518,10561,459,32768,917,86493,847,38594,159,095110,420,39482,034,68600-158,571,532
CFO
126m
+347.65%
-24,215,7002,699,20032,535,24030,065,36946,106,51100093,923,3649,944,111028,121,714125,886,030
Dividend
Jun 18, 20200.08 CNY/sh
Earnings
May 20, 2025

Profile

Thalys Medical Technology Group Inc. engages in the medical intensive business and operation services in China. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Inc. in September 2020. Thalys Medical Technology Group Inc. was founded in 2004 and is headquartered in Wuhan, China.
URL
https://www.thalys.net.cn/
IPO date
Oct 31, 2016
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
2,006,134
-13.10%
2,308,632
-11.19%
2,599,547
22.30%
Cost of revenue
1,868,759
2,089,212
2,293,298
Unusual Expense (Income)
NOPBT
137,376
219,419
306,249
NOPBT Margin
6.85%
9.50%
11.78%
Operating Taxes
(35,728)
14,271
Tax Rate
4.66%
NOPAT
173,104
219,419
291,978
Net income
(158,572)
 
Dividends
(38,796)
Dividend yield
1.81%
Proceeds from repurchase of equity
(1)
BB yield
0.00%
Debt
Debt current
443,695
876,682
823,071
Long-term debt
629,621
590,854
846,331
Deferred revenue
65
145
149
Other long-term liabilities
21,527
48,820
9,260
Net debt
517,292
690,210
928,721
Cash flow
Cash from operating activities
125,886
28,122
CAPEX
(40,825)
Cash from investing activities
15,194
159,710
Cash from financing activities
(214,307)
61,392
FCF
607,400
509,676
(9,544)
Balance
Cash
278,586
394,544
485,550
Long term investments
277,438
382,783
255,132
Excess cash
455,717
661,895
610,704
Stockholders' equity
560,131
851,376
1,098,445
Invested Capital
1,921,017
2,283,920
2,714,974
ROIC
8.23%
8.78%
11.82%
ROCE
5.75%
7.43%
9.19%
EV
Common stock shares outstanding
193,380
190,834
190,811
Price
11.09
0.45%
11.04
-23.28%
14.39
-12.63%
Market cap
2,144,583
1.79%
2,106,812
-23.27%
2,745,766
-14.26%
EV
2,765,655
2,891,030
3,855,320
EBITDA
212,086
303,773
402,530
EV/EBITDA
13.04
9.52
9.58
Interest
76,188
98,760
82,776
Interest/NOPBT
55.46%
45.01%
27.03%